Whalesbook
Q4 Earnings: Pharma Profit Plunges as Fintech Firms Turn Profitable
Indian corporate earnings for the fourth quarter of fiscal year 2026, released on May 12, 2026, showed a stark contrast. Pharmaceutical giant Dr. Reddy's Laboratories reported an 86% year-on-year profit drop, while fintech firm MobiKwik returned to profitability. This divergence highlighted a challenging earnings season where sector-specific pressures and one-time events significantly impacted results, even as some sectors showed strong growth.
Key Drivers: Pharma Challenges and Fintech Revival
Dr. Reddy's Laboratories reported an 86.2% decline in its net profit to ₹220.1 crore for Q4 FY26. The sharp fall was mainly due to significant one-time charges: a ₹453 crore shelf stock adjustment for lenalidomide, ₹228 crore in impairment charges for CAR-T assets, and ₹114 crore for VAT liability provisions. Revenue also contracted by 11.64% year-on-year to ₹7,516.2 crore. While adjusted revenues showed a less severe decline excluding these exceptional items, the reported figures raised investor concerns, leading to a negative stock reaction.
MobiKwik Systems achieved a net profit of ₹4.38 crore in Q4 FY26, a turnaround from the ₹56 crore loss in the same quarter last year. This return to profitability was driven by cost controls and improved efficiency, with revenue growing 7.8% year-on-year to ₹289 crore. Despite the profit gain, the stock declined 3.5%, indicating market caution over flat sequential profitability and continued investments in new segments.
Diverse Performance Across Sectors
Q4 FY26 results also revealed strong performance from industrial and manufacturing companies. MTAR Technologies reported revenue soaring 67.2% year-on-year to ₹306.1 crore and net profit leaping 222.3% to ₹44.3 crore. Inox India saw a 15% rise in net profit to ₹75.2 crore on a 25% revenue climb, driven by its cryogenic equipment and industrial gas solutions. Berger Paints India posted a healthy 27.5% increase in net profit to ₹335 crore, benefiting from 11.8% volume growth, an improved product mix, and lower raw material costs that expanded gross margins. Tata Power reported an 8.3% rise in consolidated net profit to ₹1,415.52 crore, with its renewable energy and transmission businesses driving results despite a 13% revenue dip.
However, some sectors faced challenges. Dixon Technologies, a major electronics manufacturer, reported a 36% fall in Q4 FY26 net profit to ₹256 crore on 2% revenue growth. This was due to margin compression from rising component costs and the end of the production-linked incentive (PLI) scheme that previously supported margins. In the gaming sector, Nazara Technologies reported a threefold jump in net profit to ₹55.7 crore, despite a 24% revenue decline, boosted by substantial 'other income' and lower operating expenses. Texmaco Rail & Engineering saw a 62% profit rise to ₹58 crore on slightly higher revenue, supported by a large $430 million export order and a ₹200 crore investment in its defence subsidiary.
Analyst Concerns and the Bear Case
Dr. Reddy's Laboratories' Q4 performance raises concerns about its profitability sustainability. The sharp drop in net profit, margin compression to 5.09% from 23.49% a year ago, and revenue contraction highlight significant operational challenges. While the company cited one-time items, their scale suggests deeper issues impacting its core business, especially with the lenalidomide patent expiry and market price erosion. Relying on 'other income' or asset write-downs to offset operational performance can signal underlying problems.
Dixon Technologies faces pressure from the expiry of the mobile production PLI scheme, which had provided a key margin buffer. Reported margin contraction and expectations of near-term pressure before backward integration benefits emerge suggest a cautious outlook. For MobiKwik, while returning to profit is positive, flat sequential growth and its stock decline indicate investors seek stronger revenue expansion and sustained profitability beyond cost-saving measures.
Looking Ahead
As the Q4 FY26 earnings season concludes, investors are focused on earnings quality, revenue growth, and margin sustainability, not just headline profit numbers. The mixed results show how economic factors, sector policies (like PLI expiry), and company events heavily influence performance. Companies with consistent revenue growth, disciplined costs, and expanding margins, such as Berger Paints and MTAR Technologies, are likely to earn investor confidence. Conversely, those relying on one-time gains or facing structural challenges, like Dr. Reddy's and Dixon Technologies, will face increased scrutiny over their future earnings and competitive strength.